Additionally, LOX inhibition synergized with gemcitabine to kill tumour cells by altering stroma, which in the case of pancreatic cancer resulted in reduced fibrillar collagen and increased vasculature [49]. The gene discussed is LOX; the disease is pancreatic neoplasm.